Madrigal Pharmaceuticals, Inc. MDGL Geographic — Operating Lease ROU Assets
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
In April 2025, the Company entered into an operating lease for additional office space in West Conshohocken, Pennsylvania. The lease commenced in May 2025 and resulted in a $4.0 million right-of-use asset and lease liability. In March 2026, the Company entered into an amendment to this lease, which modified the lease term and payment schedule. As a result, the right-of-use asset and lease liability balances were remeasured to $4.0 million and $4.6 million, respectively.
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s geographic — operating lease ROU assets?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported geographic — operating lease ROU assets of $4M in Q2 2026.
- What does geographic — operating lease ROU assets mean?
- This metric represents the capitalized value of the right to use leased office or laboratory space located in West Conshohocken, Pennsylvania, over the remaining lease term. It reflects the non-current asset recognized on the balance sheet under ASC 842 accounting standards for real estate commitments. This asset value is essential for understanding the company's long-term physical footprint and fixed operational commitments in its primary corporate hub.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s geographic — operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
